Invesco’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.67M Buy
684,519
+74,712
+12% +$150K ﹤0.01% 2626
2025
Q4
$835K Buy
609,807
+84,494
+16% +$111K ﹤0.01% 2989
2025
Q3
$651K Buy
525,313
+128,801
+32% +$154K ﹤0.01% 3123
2025
Q2
$448K Buy
396,512
+111,305
+39% +$148K ﹤0.01% 3202
2025
Q1
$416K Buy
285,207
+157,721
+124% +$297K ﹤0.01% 3225
2024
Q4
$272K Buy
127,486
+8,359
+7% +$20.6K ﹤0.01% 3445
2024
Q3
$334K Sell
119,127
-1,011
-0.8% -$2.69K ﹤0.01% 3383
2024
Q2
$280K Sell
120,138
-545
-0.5% -$1.61K ﹤0.01% 3529
2024
Q1
$539K Buy
120,683
+18,707
+18% +$78.1K ﹤0.01% 3292
2023
Q4
$327K Buy
101,976
+8,464
+9% +$24K ﹤0.01% 3404
2023
Q3
$296K Buy
93,512
+1,242
+1% +$5.44K ﹤0.01% 3464
2023
Q2
$459K Sell
92,270
-2,738
-3% -$14.8K ﹤0.01% 3286
2023
Q1
$469K Buy
95,008
+5,201
+6% +$33.4K ﹤0.01% 3294
2022
Q4
$565K Sell
89,807
-384
-0.4% -$3.56K ﹤0.01% 3206
2022
Q3
$974K Sell
90,191
-507,974
-85% -$6.9M ﹤0.01% 2935
2022
Q2
$6.82M Buy
598,165
+515,612
+625% +$4.58M ﹤0.01% 2107
2022
Q1
$751K Buy
82,553
+45,352
+122% +$472K ﹤0.01% 3208
2021
Q4
$556K Buy
37,201
+2,091
+6% +$36.9K ﹤0.01% 3345
2021
Q3
$902K Sell
35,110
-4,301
-11% -$102K ﹤0.01% 3153
2021
Q2
$1.03M Buy
39,411
+18,236
+86% +$520K ﹤0.01% 3114
2021
Q1
$747K Buy
21,175
+848
+4% +$28.6K ﹤0.01% 3172
2020
Q4
$513K Buy
20,327
+7,896
+64% +$257K ﹤0.01% 3191
2020
Q3
$468K Sell
12,431
-176
-1% -$6.64K ﹤0.01% 3142
2020
Q2
$539K Sell
12,607
-1,123
-8% -$40.6K ﹤0.01% 3093
2020
Q1
$267K Buy
+13,730
New +$327K ﹤0.01% 3309

Other funds holding ALLO